{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":3,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":3,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"abebaf0f6325","filters":{"venue":"Blood and Lymphatic Cancer Targets and Therapy"}},"results":[{"id":"W2772944194","doi":"10.2147/blctt.s132060","title":"Blastic plasmacytoid dendritic cell neoplasm: challenges and future prospects","year":2017,"lang":"en","type":"review","venue":"Blood and Lymphatic Cancer Targets and Therapy","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Foothills Medical Centre; University of Calgary","funders":"","keywords":"Interleukin-3 receptor; Plasmacytoid dendritic cell; Myeloid leukemia; Medicine; Venetoclax; Immunotherapy; Myeloid; Leukemia; Lymphoma; Oncology; Immunology; Cancer research; Internal medicine; Cancer; Dendritic cell; Immune system; Chronic lymphocytic leukemia","authors":[{"name":"Amy M. Trottier","is_ca":true},{"name":"Sonia Cerquozzi","is_ca":true},{"name":"Carolyn Owen","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06908194046716576,"gpt":0.3568258328567061,"spread":0.2877438923895403,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007503991,0.0005403705,0.001173023,0.0022815,0.0003595013,0.001279283,0.0007898393,0.00124824,0.004551438],"category_scores_gemma":[0.001297925,0.0002260127,0.0005457766,0.002077504,0.0005818573,0.00244593,0.0007159355,0.00208804,0.001714829],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006352984,"about_ca_system_score_gemma":0.001699827,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00100121,"about_ca_topic_score_gemma":0.002154522,"domain_scores_codex":[0.9998181,0.0000332154,0.00003566903,0.00003158236,0.00005946905,0.00002199348],"domain_scores_gemma":[0.9992131,0.0003419203,0.00009606166,0.00002251833,0.0002411179,0.00008538769],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00007602185,0.00006077539,0.0002856397,0.01721317,0.00005702099,0.0004036855,0.00009355799,0.0003223591,0.0009591526,0.005246202,0.05226733,0.9230151],"study_design_scores_gemma":[0.00001149458,0.00005105248,0.0005962217,0.00509818,0.00009179612,0.002433951,0.000133148,0.00009004191,0.0001647265,0.003498108,0.9878143,0.00001699921],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00009874449,0.9975539,0.00008582769,0.001173937,0.0003788714,0.000002200892,0.00001182082,0.000008065792,0.0006866058],"genre_scores_gemma":[0.0005744213,0.9980344,0.0001402887,0.0004709138,0.0003888822,0.000003011803,0.00002115029,0.00000145377,0.0003655024],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004551438,"threshold_uncertainty_score":0.01522607,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2498089677","doi":"10.2147/blctt.s84157","title":"Waldenström macroglobulinemia: biology, genetics, and therapy","year":2016,"lang":"en","type":"review","venue":"Blood and Lymphatic Cancer Targets and Therapy","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"St. Stephen's University","funders":"","keywords":"Ibrutinib; Waldenstrom macroglobulinemia; Bruton's tyrosine kinase; Medicine; Lymphoplasmacytic Lymphoma; Rituximab; Oncology; Lymphoma; Macroglobulinemia; CXCR4; Internal medicine; Germline mutation; Cancer research; Immunology; Leukemia; Chronic lymphocytic leukemia; Biology; Mutation; Tyrosine kinase; Genetics; Multiple myeloma; Receptor","authors":[{"name":"Stephen M. Ansell","is_ca":true},{"name":"Jonas Paludo","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06055768449692186,"gpt":0.3826594748749941,"spread":0.3221017903780722,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003866974,0.0004926529,0.0003898855,0.000579173,0.0003139733,0.0007876029,0.0003108099,0.0007525657,0.001826779],"category_scores_gemma":[0.0005633337,0.00008518283,0.0001737541,0.0004299199,0.0004303103,0.0003848634,0.00049788,0.001128823,0.001047985],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009754986,"about_ca_system_score_gemma":0.0005845772,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006169857,"about_ca_topic_score_gemma":0.001293591,"domain_scores_codex":[0.9998493,0.00003308716,0.00001192452,0.00001597403,0.00005961837,0.00003002464],"domain_scores_gemma":[0.9998751,0.0000210931,0.00002924237,0.000004930609,0.00002268997,0.00004700808],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003566974,0.0002904184,0.009950854,0.0006205675,0.00007114613,0.006830821,0.0001172114,0.000808773,0.009205976,0.01233291,0.09162208,0.8677925],"study_design_scores_gemma":[0.000341992,0.001137943,0.01828524,0.001344967,0.0001104291,0.03893325,0.0001273825,0.002125078,0.007606432,0.01111069,0.9188139,0.00006274495],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.07993923,0.7794657,0.003539378,0.05136369,0.003260012,0.0001148306,0.0003310071,0.0003947486,0.0815914],"genre_scores_gemma":[0.6429956,0.2912787,0.007797085,0.01553081,0.007328317,0.0002034886,0.0007500161,0.00005550028,0.03406047],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.001826779,"threshold_uncertainty_score":0.007077813,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2052425543","doi":"10.2147/blctt.s44343","title":"MicroRNA dysregulation in B-cell non-Hodgkin lymphoma","year":2013,"lang":"en","type":"article","venue":"Blood and Lymphatic Cancer Targets and Therapy","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Lymphoma; microRNA; Hodgkin lymphoma; Immune dysregulation; Cancer research; Biology; Immunology; Genetics; Gene; Immune system","authors":[{"name":"Marco A. Marra","is_ca":true},{"name":"Lim","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.005049668615530808,"gpt":0.2192365307887121,"spread":0.2141868621731813,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002068319,0.0002139177,0.0003801662,0.0003984857,0.000120036,0.0003994982,0.0001372553,0.0003052735,0.001061563],"category_scores_gemma":[0.000235725,0.00006517928,0.0001621767,0.0004410828,0.0001209685,0.0002336942,0.0002358037,0.0003320179,0.0005123158],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002462021,"about_ca_system_score_gemma":0.0002446728,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001812665,"about_ca_topic_score_gemma":0.0002844067,"domain_scores_codex":[0.9998968,0.00002650514,0.00001590071,0.00001910642,0.00003081918,0.00001094336],"domain_scores_gemma":[0.9999477,0.00001626471,0.00001359971,0.000001692344,0.00001507594,0.000005755897],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.0004230654,0.00007792573,0.00612258,0.008869819,0.0002166475,0.002265326,0.0002563698,0.0008007496,0.1620072,0.00426767,0.01625303,0.7984396],"study_design_scores_gemma":[0.00009824772,0.0008238145,0.0322645,0.001650855,0.000520022,0.01980285,0.0003168585,0.001343751,0.08303346,0.00381795,0.8562793,0.00004835524],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.02639898,0.9649239,0.001816373,0.0007927151,0.0004259981,0.00002641874,0.0001714895,0.00009095403,0.005353262],"genre_scores_gemma":[0.1561219,0.8350132,0.00284112,0.0008564071,0.0003823794,0.00005960999,0.0003577307,0.00001766458,0.004350047],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.001061563,"threshold_uncertainty_score":0.003551245,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}